Literature DB >> 29267455

Granuloma annulare treated with narrowband UVB phototherapy.

Bianca Pinheiro Bousquet Muylaert1, Roberta Almada2, Rossana Cantanhede Farias de Vasconcelos1.   

Abstract

Granuloma annulare is a benign cutaneous inflammatory disease, whose lesions have spontaneous improvement in two years in 50% of cases, but there is recurrence in 40% of patients. Treatment may be topical, intralesional or systemic. The use of phototherapy with narrowband UVB is highlighted, whose mechanism of action in this disease is still unclear, probably related to the inhibition of T lymphocytes. Herein, a case of a disseminated granuloma annulare of difficult therapeutic management is described. It was treated with narrowband UVB phototherapy twice a week for six months, with good clinical improvement, being a good low-risk therapeutic option and that, in this case, provided quick and satisfactory response.

Entities:  

Mesh:

Year:  2017        PMID: 29267455      PMCID: PMC5726686          DOI: 10.1590/abd1806-4841.20174994

Source DB:  PubMed          Journal:  An Bras Dermatol        ISSN: 0365-0596            Impact factor:   1.896


INTRODUCTION

Granuloma annulare (GA) is a benign inflammatory skin condition that classically presents as non-itchy, coalescent annular plaques, usually located on the dorsum of the hands.[1] It occurs in all age groups, and is rare in childhood. There are the localized and subcutaneous types (that usually affect children and young adults), the disseminated type (more common in female adults), and the perforating and macular types.[2,3] The histology is characterized by complete or incomplete collagen necrobiosis, associated to an inflammatory infiltrate represented by macrophages in particular, that are placed in between and around degenerated collagen fibers.[2] The lesions resolve spontaneously in two years in 50% of the cases. However, 40% of patients recur and the condition can also persist for years, causing an impact in the patient’s quality of life.[3] We present a case of disseminated GA with difficult management.

CASE REPORT

Sixty-one-year-old female patient had asymptomatic lesions on the back, that spread to the chest and upper limbs two months before the first consultation. She had diabetes mellitus, for which she used metformin; hypothyroidism, for which she used levothyroxine; dyslipidemia, for which she used simvastatin; and had donated a kidney 26 years back. On dermatological examination, there were erythematous, confluent papules in an annular pattern, with centrifugal spread and normochromic center on the back, chest and upper limbs (Figures 1 to 3). The differential diagnoses were erythema annulare centrifugum and granuloma annulare.
Figure 1

Erythematous plaques with an annular configuration on the chest

Figure 3

Erythematous plaques with an annular configuration on the arm

Erythematous plaques with an annular configuration on the chest Erythematous plaques with an annular configuration on the arm A biopsy was done on the chest and the histology showed superficial interstitial granulomatous dermatitis with mild mucinosis. It was suggestive of interstitial GA. Sulfone treatment was commenced at 100mg/day and discontinued after three days due to hematuria. She was then treated with intramuscular betamethasone, clobetasol cream under occlusion and cryotherapy, with no significant improvement of the lesions. We opted to prescribe narrowband UVB phototherapy twice a week for six months, with 48 sessions in total and cumulative dose of 13,440J/cm2. She showed response after the third week, with good tolerance to the treatment and complete resolution of the lesions in the end. Two years after finishing the treatment, the patient is still undergoing follow up every six months, with no recurrence and is in use of moisturizers only (Figure 4).
Figure 4

A and B. Post-treatment with narrowband UVB phototherapy

A and B. Post-treatment with narrowband UVB phototherapy

DISCUSSION

Disseminated GA presents as disseminated papules, some of which coalesce to form small annular plaques or large discolored patches, with raised, arcuate and serpiginous margins. Face and genital area are usually spared.[4] This type is responsible for 8 to 15% of the cases, especially in female adult patients and is strongly linked to hypercholesterolemia.[3] GA is associated with diabetes mellitus, thyroid diseases, dyslipidemia, rheumatoid arthritis and malignancies, such as lymphomas.[5] Its etiology is unknown and the pathogenesis poorly understood, being also associated with insect bites, minor trauma, HIV infection, tuberculin test, sun exposure, viral infections, among others.[2] GA frequently resolves spontaneously in two years, many times after a biopsy, and usually does not leave any atrophic sequelae.[2,3] Gunes et al. described that the damage to the elastic fibers is one of the main features of GA and it can originate from delayed-type hypersensitivity. Thus, the destruction of elastic fibers may be intrinsic to GA, being strong enough to cause visible cutaneous atrophy such as anetoderma.[4] Treatment can be topical, with tacrolimus, pimecrolimus, imiquimod, steroid, cryotherapy and phototherapy. It can be intralesional, with interferon and steroid or systemic, with antimalarials, retinoids, steroids, ciclosporine, dapsone, infliximab, etanercept e efalizumab.[2,5] Treatment with rifampicin, ofloxacine and minocycline was described with good response.[5,6] Disseminated GA usually presents with a prolonged clinical course, difficult to be treated. Phototherapy is the exposure to ultraviolet radiation for therapeutic purposes and can be done using natural light, ultraviolet A (UVA) or ultraviolet B (UVB). Controlled and repeated exposures to ultraviolet light are used, in order to change the cutaneous pathophysiology and induce regression or control of progression of dermatoses. Both UVA and UVB are capable of altering cellular DNA.[7] The mechanism of action of phototherapy in GA is still uncertain but is apparently associated to the inhibition of T lymphocytes and the resulting effects on the macrophage and metalloproteinases production.[2] It is believed to be a delayed-type hypersensitivity mechanism in the pathogenesis of GA against unknown antigens in the skin.[8] In the literature, there are two reports of GA treated with narrowband UVB. The first one was in 2005, with remission after 24 weekly sessions and no recurrence after six months of follow-up.[9] The second was in 2015 after 27 sessions, three times a week, with maintained remission after one year of follow-up.[10] In this case, the number of sessions was higher, also with satisfactory results, with quick and complete regression of the condition and no recurrence after two years of follow-up. The objective of this case report was to illustrate a case of disseminated GA refractory to treatment due to the patient’s comorbidities, since the use of steroids was limited by diabetes mellitus and sulfone had to be discontinued due to hematuria. We must highlight the favorable result after narrowband UVB phototherapy, making it a good therapeutic option with few side effects and contraindications, appropriate for patients with multiple comorbidities.
  9 in total

1.  Disseminated granuloma annulare responsive to narrowband ultraviolet B therapy.

Authors:  Shigeki Inui; Yoko Nishida; Satoshi Itami; Ichiro Katayama
Journal:  J Am Acad Dermatol       Date:  2005-09       Impact factor: 11.527

2.  Psoralen and ultraviolet A in the treatment of granuloma annulare.

Authors:  Fiona Browne; David Turner; Victoria Goulden
Journal:  Photodermatol Photoimmunol Photomed       Date:  2011-04       Impact factor: 3.135

3.  Phototherapy with UV-A-I for generalized granuloma annulare.

Authors:  S Muchenberger; E Schöpf; J C Simon
Journal:  Arch Dermatol       Date:  1997-12

4.  Successful Treatment of Disseminated Granuloma Annulare With Narrowband UV-B Phototherapy.

Authors:  G Solano-López; M J Concha-Garzón; D de Argila; E Daudén
Journal:  Actas Dermosifiliogr       Date:  2014-10-11

5.  Granuloma annulare treated with rifampin, ofloxacin, and minocycline combination therapy.

Authors:  Dione V Marcus; Bassel H Mahmoud; Iltefat H Hamzavi
Journal:  Arch Dermatol       Date:  2009-07

6.  Collagen-elastic tissue changes and vascular involvement in granuloma annulare: a review of 35 cases.

Authors:  Pembegül Güneş; Fatih Göktay; A Tülin Mansur; Filiz Köker; Gamze Erfan
Journal:  J Cutan Pathol       Date:  2008-11-09       Impact factor: 1.587

7.  Solitary Granuloma Annulare: The First Case of Development on a Healthy Child's Palm.

Authors:  Chan Ho Na; Min Sung Kim; Sang Hyun Song; Bong Seok Shin
Journal:  Ann Dermatol       Date:  2014-02-17       Impact factor: 1.444

8.  Generalized granuloma annulare treated with monthly rifampicin, ofloxacin, and minocycline combination therapy.

Authors:  Shilpa Garg; Sukriti Baveja
Journal:  Indian J Dermatol       Date:  2013-05       Impact factor: 1.494

9.  Remission of generalized erythematous granuloma annulare after improvement of hyperlipidemia and review of the Japanese literature.

Authors:  Soko Watanabe; Masaru Tanaka; Ken Kobayashi; Mizuki Sawada; Sumiko Ishizaki; Koji Tsurui; Mariko Fujibayashi
Journal:  Dermatol Pract Concept       Date:  2014-01-31
  9 in total
  2 in total

Review 1.  Phototherapy in dermatological maladies (Review).

Authors:  Daciana Elena Branisteanu; Diana Stefania Dirzu; Mihaela Paula Toader; Daniel Constantin Branisteanu; Alin Codrut Nicolescu; Ilarie Brihan; Camelia Margareta Bogdanici; George Branisteanu; Andreea Dimitriu; Nicoleta Anton; Elena Andrese Porumb
Journal:  Exp Ther Med       Date:  2022-02-03       Impact factor: 2.447

Review 2.  Granuloma Annulare: An Updated Review of Epidemiology, Pathogenesis, and Treatment Options.

Authors:  Tejas P Joshi; Madeleine Duvic
Journal:  Am J Clin Dermatol       Date:  2021-09-08       Impact factor: 7.403

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.